Sep 11 |
GSK’s experimental herpes shot fails in early trial
|
Sep 11 |
Buyout Firm GTCR Is in Advanced Talks to Acquire German Drugmaker Stada
|
Sep 6 |
GSK’s Nucala succeeds in late-stage study for lung disorder, COPD
|
Sep 3 |
With 86% institutional ownership, GSK plc (LON:GSK) is a favorite amongst the big guns
|
Aug 30 |
Why Is Glaxo (GSK) Up 10.3% Since Last Earnings Report?
|
Aug 28 |
GSK plc (GSK): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
|
Aug 28 |
Five alternatives to Mag 7 stocks if you missed out on Nvidia
|
Aug 28 |
GSK shares rise on Delaware Supreme Court appeal in Zantac case
|
Aug 27 |
GSK stock climbs on Delaware court ruling in Zantac case
|
Aug 26 |
GSK's Q2 Success Amid Challenges: What Investors Need To Know
|